RecruitingNot ApplicableNCT05432479

Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief

A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief

Sponsor

The Archer-Daniels-Midland Company

Enrollment

80 participants

Start Date

Sep 30, 2022

Study Type

INTERVENTIONAL

Conditions

Infantile colic

Summary

This study evaluates the efficacy of single strain probiotic administered in a form of a sachet in the treatment of infant colic in infants 3-12 weeks old.

Eligibility

Min Age: 3 WeeksMax Age: 12 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and Probiotic for people with infantile colic. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 3 Weeks to 12 Weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTProbiotic

Single strain probiotic in a form of a sachets with a daily dose of 1.0E+9 Colony Forming Unit (CFU) per day for 4 weeks

DIETARY_SUPPLEMENTPlacebo

Placebo

Locations(2)

Atlantia Food Clinical Trials

Chicago, Illinois, United States

Pulse Multispeciality Hospital,

Pune, Maharashtra, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05432479

Related Trials

BioAmicus Complete for Functional Gastrointestinal Symptoms in Infants Aged 0 to 24 Months

NCT071485831 location

Evaluating the Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying and Fussing Time in Infants With Colic

NCT071908594 locations

Effect of Probiotics on Infantile Colic Symptoms

NCT0638505410 locations